Listed drug company recorded 6.34% growth in FY1999

Published: 2000-06-01 07:30:00

Updated: 2000-06-01 07:30:00

7 listed drug companies having fiscal year ended at March 31 took shareholders' meetings on May 27, which included Daewoong, Dongwha, Il Yang, Ildong, Bukwang, Kukje and Yuyu (Hanil on payment rescheduling excluded). The total sales of these 7 companies showed 627,470 million won, 6.34% increase ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK